These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25404476)

  • 1. Flow Cytometric Quantification of Intraperitoneal Free Tumor Cells is a Useful Biomarker in Gastric Cancer Patients with Peritoneal Metastasis.
    Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Onoyama H; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
    Ann Surg Oncol; 2015 Jul; 22(7):2336-42. PubMed ID: 25404476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric quantification of intraperitoneal free tumor cells in patients with peritoneal metastasis.
    Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
    Cytometry B Clin Cytom; 2014 Jan; 86(1):56-62. PubMed ID: 24115348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric quantification of intraperitoneal free tumor cells (FTC) in patients with peritoneal metastasis.
    Kitayama J; Emoto S; Yamaguchi H; Ishigami H; Kamei T; Yamashita H; Seto Y; Matsuzaki K; Watanabe T
    Cytometry B Clin Cytom; 2013 Aug; ():. PubMed ID: 24038963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer.
    Takahashi K; Kurashina K; Saito S; Kanamaru R; Ohzawa H; Yamaguchi H; Miyato H; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Cytometry B Clin Cytom; 2021 Nov; 100(6):666-675. PubMed ID: 33277773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal involvement and free tumor cells in peritoneal cavity of patients with colon cancer.
    Douard R; Cugnenc PH; Wind P; Bénichou J
    Am J Clin Pathol; 2004 Jan; 121(1):154-5; author reply 155. PubMed ID: 14750253
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection.
    Lorenzen S; Panzram B; Rosenberg R; Nekarda H; Becker K; Schenk U; Höfler H; Siewert JR; Jäger D; Ott K
    Ann Surg Oncol; 2010 Oct; 17(10):2733-9. PubMed ID: 20490698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination].
    Sasaki K; Fujiwara Y; Kishi K; Motoori M; Sugimura K; Miyoshi N; Akita H; Gotoh K; Takahashi H; Marubashi S; Noura S; Ohue M; Yano M; Sakon M; Ishigami H; Kitayama J
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2319-21. PubMed ID: 24394098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer.
    Takahashi K; Kurashina K; Yamaguchi H; Kanamaru R; Ohzawa H; Miyato H; Saito S; Hosoya Y; Lefor AK; Sata N; Kitayama J
    Front Immunol; 2022; 13():969468. PubMed ID: 36119051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis.
    Yamaguchi H; Kitayama J; Ishigami H; Emoto S; Yamashita H; Watanabe T
    Cancer; 2013 Sep; 119(18):3354-8. PubMed ID: 23798046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC).
    Graversen M; Fristrup C; Kristensen TK; Larsen TR; Pfeiffer P; Mortensen MB; Detlefsen S
    J Clin Pathol; 2019 May; 72(5):368-372. PubMed ID: 30755498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and significance for prognosis of free gastric cancer cells in the peritoneal cavity.
    Li C; Ma Y; Xue Y; Zhang H; Wei Y
    Hepatogastroenterology; 2009; 56(91-92):891-8. PubMed ID: 19621724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive peritoneal lavage fluid cytology based on isolation by size of epithelial tumor cells indicates a high risk of peritoneal metastasis.
    Xuan Y; Gao Q; Wang C; Cai D
    PeerJ; 2024; 12():e17602. PubMed ID: 38952968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of peritoneal washing cytology for the detection of free peritoneal cancer cells before and after surgical treatment of gastric adenocarcinoma.
    Hasbahceci M; Akcakaya A; Guler B; Kunduz E; Malya FU; Muslumanoglu M
    J Cancer Res Ther; 2018; 14(6):1225-1229. PubMed ID: 30488834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery.
    Yonemura Y; Endou Y; Shinbo M; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Mizuno M; Miura M; Ikeda M; Ikeda S; Nakajima G; Yonemura J; Yuuba T; Masuda S; Kimura H; Matsuki N
    J Surg Oncol; 2009 Sep; 100(4):311-6. PubMed ID: 19697437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination.
    Fujiwara Y; Nishida T; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Yamamoto K; Moon JH; Mori M; Doki Y
    Anticancer Res; 2010 Apr; 30(4):1335-9. PubMed ID: 20530449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
    Kobayashi D; Kodera Y
    Gastric Cancer; 2017 Mar; 20(Suppl 1):111-121. PubMed ID: 27803990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.